Maitz MF, Lenz R, Winkler S, Abschke MF, Werner C, Fischer D
50 ml vial
The imbalance of gut microbiota will reduce the production of SCFAs, weaken the ability to activate SCFAs receptors, and affect GLP-1 secretion, resulting in abnormal glucose metabolism and lipid metabolism (Ma et al., 2019)
Always consult a licensed healthcare provider before making changes to your care
An Overview of Ozempic Ozempic is a medication containing the active ingredient semaglutide and is approved by the FDA for use in managing type 2 diabetes
The program primarily uses compounded semaglutide and compounded tirzepatide, prescribed by licensed providers after a medical evaluation